Table 2.

Cases Undergoing Mutational Evaluation and primary tumor parameters.

Case #	Age at diagnosis	LVI	perineural invasion	Midline/bilateral involvement	regression	satellitosis	tumor thickness	ulceration	mitotic rate per sq mm	LN	Tumor
1	60	absent	absent	no	absent	absent	2.0 mm	no	1 per sq mm	2+	primary
2	65	absent	present	yes	absent	present	6.0 mm	yes	2	1+	primary
3*	68	absent	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
4	72	present	present	n/a	absent	absent	13.0 mm	yes	8	n/a	primary
5	69	absent	absent	n/a	absent	absent	3.0 mm	yes	1	5−	primary
6*	74	absent	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
7	59	absent	absent	n/a	present	absent	2.45 mm	yes	1	5−	primary
8	80	absent	absent	no	absent	present	2.4 mm	no	0	2+	primary
9	77	absent	absent	n/a	absent	absent	4.3 mm	yes	1	3−	primary
10*	70	absent	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
11	54	absent	absent	yes	present	absent	1.4 mm	no	1	4−	primary
12	87	absent	absent	n/a	absent	absent	6.0 mm	yes	11	n/a	recurrent lesion
13	66	absent	absent	n/a	absent	absent	4.1 mm	yes	2	n/a	recurrent lesion
14	70	absent	absent	n/a	absent	absent	17.2 mm	yes	3	2+	primary
15	82	absent	absent	n/a	present	absent	0.45 mm	no	0	n/a	primary
16	62	absent	absent	n/a	n/a	absent	6.0 mm	no	2	2−	primary

LVI: Lymphovascular invasion. “Sq”: Square. LN: Lymph node. n/a: not available or applicable.

^*melanoma in situ cases.